Menu Close

2026 ILC Symposium Speakers

Wednesday, September 23, 2026

Opening of 2026 International Invasive Lobular Carcinoma Symposium: Welcome

Debate 1: Tumor morphology alone should be used to diagnose ILC

Scientific Session 1: Genetics, Risk, and Exposures

Scientific Session 2: The ILC Cell and Microenvironment

Thursday, September 24, 2026

Scientific Session 3: Mechanisms of Metastasis

Debate 2: Cytotoxic chemotherapy is ineffective in patients with metastatic ILC

Scientific Session 4: Model Systems & Pathology

Keynote Address 1: Hereditary CDH1 Mutations: The identification and evolution of a cancer syndrome

Scientific Session 5: Diagnostics and Clinical Management

Scientific Session 6: Clinical Trial Results & Advocacy

Friday, September 25, 2026

Scientific Session 7: Endocrine Resistance & Novel Targets

Keynote Address 2: Novel approaches to screening and clinical trials for breast cancer: how to improve care for ILC

Laura Esserman, MD, MBA
Director, Breast Care Center, University of California, San Francisco

Scientific Session 8: Advanced Imaging and Artificial Intelligence

Dynami Foundation Leigh Pate Memorial Lecture

Steffi Oesterreich, PhD
Professor, Univ of Pittsburgh, Co-Director, Women’s Cancer Research Center, Co-Leader Cancer Biology Program, UPMC HCC and MWRI

Scientific Session 9: SNMMI Special Session – Imaging in ILC

Scientific Session 10: Radiotherapy, Clinical Trials

Debate 3: Patients with ILC should be treated with neoadjuvant therapy